Aclarion Inc Receivables Turnover Ratio (ACON), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Aclarion Inc   (NASDAQ: ACON)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Aclarion Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Aclarion Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 2.57, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Aclarion Inc in Jun 30 2026 quarter, has decreased to 142 days, compared to 144 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 500 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3260, from overall ranking in the first quarter 2026 at 3629.

What is Receivable Turnover Ratio?
What is Aclarion Inc Selling?


What is Receivable Turnover Ratio?





ACON Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change 34.67 % 111.68 % 61.96 % 88.89 % 6.12 %
Y / Y Revenue Change 30.48 % 11.32 % 80.59 % 31.48 % 76.09 %
Receivable Turnover Ratio (TTM) 2.57 2.53 2.98 2.98 3.34
ACON's Total Ranking # 3260 # 3629 # 3312 # 3282 # 3374
Accounts Receivable average collection period days 142 144 123 122 109
Seq. Receivable Change -30.58 % 36.74 % -7.3 % 53.05 % 9.12 %
Seq. Revenue Change 19.24 % 14.41 % -2.45 % -1.95 % 1.73 %


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry # 29
Healthcare Sector # 501
Overall Market # 3260

Receivable Turnover Ratio Statistics
High Average Low
5 3.48 2.53
(Sep 30 2023)   (Mar 31 2026)






Financial Statements
Aclarion Inc 's Accounts Receivable $ 0 Millions Visit ACON's Balance sheet
Aclarion Inc 's Sales TTM $ 0 Millions Visit ACON's Income Statement
Sources of ACON's Revenues Visit ACON's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ACON's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ACON's Growth Rates ACON's Roa ACON's Inventory Turnover Ratio ACON's Dividend Comparisons
ACON's Profitability Ratios ACON's Roi ACON's Asset Turnover Ratio ACON's Dividend Growth
ACON's Valuation Ratios ACON's Roe ACON's Financial Strength Ratios ACON's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Adapthealth Corp   8.14 $ 3,226.709  Millions$ 396.643  Millions
Seastar Medical Holding Corp  8.11 $ 1.713  Millions$ 0.211  Millions
Atricure Inc   8.08 $ 567.747  Millions$ 70.232  Millions
Concentra Group Holdings Parent Inc   8.07 $ 2,287.465  Millions$ 283.300  Millions
Sanuwave Health Inc   8.04 $ 43.903  Millions$ 5.461  Millions
Aveanna Healthcare Holdings Inc   8.03 $ 2,602.820  Millions$ 324.026  Millions
Sotera Health Company  8.01 $ 1,215.925  Millions$ 151.745  Millions
Avita Medical Inc   7.99 $ 75.631  Millions$ 9.463  Millions
Alphatec Holdings Inc   7.94 $ 814.780  Millions$ 102.662  Millions
Tenet Healthcare Corp  7.92 $ 21,812.000  Millions$ 2,752.500  Millions
Henry Schein Inc   7.91 $ 13,602.000  Millions$ 1,719.000  Millions
Tela Bio Inc   7.86 $ 80.535  Millions$ 10.243  Millions
Pacs Group Inc   7.78 $ 5,551.038  Millions$ 713.483  Millions
Vycor Medical Inc   7.68 $ 1.807  Millions$ 0.235  Millions
Idexx Laboratories Inc  7.65 $ 4,553.792  Millions$ 595.549  Millions
Sharps Technology Inc   7.65 $ 2.468  Millions$ 0.323  Millions
Natera Inc   7.61 $ 2,707.077  Millions$ 355.618  Millions
Quest Diagnostics Inc  7.56 $ 11,560.000  Millions$ 1,529.250  Millions
Fortress Biotech Inc   7.55 $ 69.983  Millions$ 9.266  Millions
Protalix Biotherapeutics inc   7.55 $ 80.619  Millions$ 10.677  Millions
Iridex Corp  7.49 $ 51.044  Millions$ 6.816  Millions
Novocure Limited  7.46 $ 699.193  Millions$ 93.686  Millions
Intuitive Surgical Inc   7.46 $ 11,296.300  Millions$ 1,513.950  Millions
Transmedics Group Inc   7.43 $ 668.468  Millions$ 89.962  Millions
Beta Bionics Inc   7.43 $ 119.513  Millions$ 16.092  Millions
Renovorx Inc   7.40 $ 1.976  Millions$ 0.267  Millions
Maravai Lifesciences Holdings Inc   7.39 $ 207.886  Millions$ 28.147  Millions
Lucid Diagnostics Inc   7.33 $ 5.445  Millions$ 0.742  Millions
Foxo Technologies Inc   7.27 $ 24.846  Millions$ 3.420  Millions
Safe Pro Group Inc   7.23 $ 2.881  Millions$ 0.399  Millions

Date modified: 2026-09-05T14:52:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.